{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:57:54Z","timestamp":1791151074518,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"vor","delay-in-days":485,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1111\/1469-0691.12212","type":"journal-article","created":{"date-parts":[[2013,4,22]],"date-time":"2013-04-22T13:38:34Z","timestamp":1366637914000},"page":"e343-e353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":181,"title":["Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme"],"prefix":"10.1016","volume":"19","author":[{"given":"M.C.","family":"Arendrup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Dzajic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.H.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.K.","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Kjaldgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D.","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Leitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.E.","family":"Lemming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Olesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.S.","family":"Rosenvinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.L.","family":"R\u00f8der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.C.","family":"Sch\u00f8nheyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/1469-0691.12212_bib1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1128\/JCM.01811-10","article-title":"National Surveillance of Fungemia in Denmark 2004\u20132009","volume":"49","author":"Arendrup","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12212_bib2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1439-0507.2005.01134.x","article-title":"Candidaemia in an Irish tertiary referral hospital: epidemiology and prognostic factors","volume":"48","author":"Boo","year":"2005","journal-title":"Mycoses"},{"key":"10.1111\/1469-0691.12212_bib3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jhin.2010.01.022","article-title":"Increasing incidence of candidaemia: long\u2010term epidemiological trends, Queensland, Australia, 1999\u20132008","volume":"76","author":"Playford","year":"2010","journal-title":"J Hosp Infect"},{"key":"10.1111\/1469-0691.12212_bib4","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/jac\/dki258","article-title":"Invasive Candida species infections: a 5\u00a0year population\u2010based assessment","volume":"56","author":"Laupland","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12212_bib5","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/cid\/cis697","article-title":"Changes in incidence and antifungal drug resistance in candidemia: results from population\u2010based laboratory surveillance in Atlanta and Baltimore, 2008\u20132011","volume":"55","author":"Cleveland","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12212_bib6","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/AAC.49.9.3640-3645.2005","article-title":"Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality","volume":"49","author":"Morrell","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12212_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/504810","article-title":"Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi\u2010institutional study","volume":"43","author":"Garey","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12212_bib8","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1128\/JCM.40.9.3489-3492.2002","article-title":"Increasing incidence of candidemia: results from a 20\u2010year nationwide study in Iceland","volume":"40","author":"Asmundsdottir","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12212_bib9","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/01.CCM.0000202208.37364.7D","article-title":"A bedside scoring system (\u201cCandida score\u201d) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization","volume":"34","author":"Leon","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1111\/1469-0691.12212_bib10","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1097\/CCM.0b013e31819daa14","article-title":"Usefulness of the \u201cCandida score\u201d for discriminating between Candida colonization and invasive candidiasis in non\u2010neutropenic critically ill patients: a prospective multicenter study","volume":"37","author":"Leon","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1111\/1469-0691.12212_bib11","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/INF.0b013e318170bb0c","article-title":"Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole\u2010resistant Candida subspecies","volume":"27","author":"Manzoni","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/1469-0691.12212_bib12","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s00134-009-1619-9","article-title":"Assessment of clinical risk predictive rules for invasive candidiasis in a prospective multicentre cohort of ICU patients","volume":"35","author":"Playford","year":"2009","journal-title":"Intensive Care Med"},{"key":"10.1111\/1469-0691.12212_bib13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/2110-5820-1-50","article-title":"Evaluation of \u201cCandida score\u201d in critically ill patients: a prospective, multicenter, observational, cohort study","volume":"1","author":"Leroy","year":"2011","journal-title":"Ann Intensive Care"},{"key":"10.1111\/1469-0691.12212_bib14","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1439-0507.2009.01756.x","article-title":"Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit","volume":"54","author":"Ostrosky\u2010Zeichner","year":"2011","journal-title":"Mycoses"},{"key":"10.1111\/1469-0691.12212_bib15","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/bmt.2010.175","article-title":"European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3\u20132009 Update","volume":"46","author":"Maertens","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/1469-0691.12212_bib16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12212_bib17","first-page":"445","article-title":"Epidemiology of invasive candidiasis","volume":"16","author":"Arendrup","year":"2010","journal-title":"Curr Opin Crit Care"},{"key":"10.1111\/1469-0691.12212_bib18","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1128\/JCM.00179-11","article-title":"Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia","volume":"49","author":"Arendrup","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12212_bib19","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/AAC.01128-10","article-title":"Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients","volume":"55","author":"Lortholary","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12212_bib20","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jinf.2007.10.014","article-title":"Increasing incidence of Candida parapsilosis candidemia with caspofungin usage","volume":"56","author":"Forrest","year":"2008","journal-title":"J Infect"},{"key":"10.1111\/1469-0691.12212_bib21","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1002\/cncr.24507","article-title":"Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001\u20132007): stable incidence but changing epidemiology of a still frequently lethal infection","volume":"115","author":"Sipsas","year":"2009","journal-title":"Cancer"},{"issue":"Suppl. 1","key":"10.1111\/1469-0691.12212_bib22","first-page":"43","article-title":"Norwegian Yeast Study Group Candidaemia in Norway","volume":"52","author":"Nord\u00f8y","year":"2009","journal-title":"Mycoses"},{"key":"10.1111\/1469-0691.12212_bib23","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/1471-2334-10-312","article-title":"Secular trend in candidemia and the use of fluconazole in Finland, 2004\u20132007","volume":"10","author":"Poikonen","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1111\/1469-0691.12212_bib24","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1469-0691.2008.01954.x","article-title":"Semi\u2010national surveillance of fungaemia in Denmark 2004\u20132006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility","volume":"14","author":"Arendrup","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12212_bib25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/00365540310017447","article-title":"A prospective epidemiological survey of candidaemia in Sweden","volume":"36","author":"Klingspor","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/1469-0691.12212_bib26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0195-6701(03)00085-9","article-title":"Management and outcome of bloodstream infections due to Candida species in England and Wales","volume":"54","author":"Kibbler","year":"2003","journal-title":"J Hosp Infect"},{"key":"10.1111\/1469-0691.12212_bib27","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1017\/S095026880400295X","article-title":"A one\u2010year survey of candidemia in Belgium in 2002","volume":"132","author":"Swinne","year":"2004","journal-title":"Epidemiol Infect"},{"key":"10.1111\/1469-0691.12212_bib28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2334-6-80","article-title":"Candidaemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible links","volume":"6","author":"Sendid","year":"2006","journal-title":"BMC Infect Dis"},{"key":"10.1111\/1469-0691.12212_bib29","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1128\/JCM.43.4.1829-1835.2005","article-title":"Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population\u2010based surveillance, Barcelona, Spain, from 2002 to 2003","volume":"43","author":"Almirante","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12212_bib30","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1099\/jmm.0.47239-0","article-title":"One year prospective survey of Candida bloodstream infections in Scotland","volume":"56","author":"Odds","year":"2007","journal-title":"J Med Microbiol"},{"key":"10.1111\/1469-0691.12212_bib31","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1469-0691.2007.01812.x","article-title":"Changing pattern of candidaemia 2001\u20132006 and use of antifungal therapy at the University Hospital of Vienna, Austria","volume":"13","author":"Presterl","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12212_bib32","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/jhin.2002.1261","article-title":"European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia: report from one Italian region","volume":"51","author":"Tortorano","year":"2002","journal-title":"J Hosp Infect"},{"key":"10.1111\/1469-0691.12212_bib33","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1128\/JCM.02390-09","article-title":"Breakthrough invasive candidiasis in patients on micafungin","volume":"48","author":"Pfeiffer","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12212_bib34","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1128\/JCM.06112-11","article-title":"Frequency of decreased susceptibility and resistance to echinocandins among fluconazole\u2010resistant bloodstream isolates of Candida glabrata","volume":"50","author":"Pfaller","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12212_bib35","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1128\/AAC.00836-10","article-title":"FKS mutations and elevated echinocandin MIC values among Candida glabrata isolates from U.S. population\u2010based surveillance","volume":"54","author":"Zimbeck","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12212_bib36","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1086\/500939","article-title":"Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient","volume":"42","author":"Krogh\u2010Madsen","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12212_bib37","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3201\/eid1801.110556","article-title":"Candida spp. with acquired echinocandin resistance, France, 2004\u20132010","volume":"18","author":"Dannaoui","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/1469-0691.12212_bib38","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1128\/JCM.42.4.1519-1527.2004","article-title":"Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population\u2010based active surveillance program","volume":"42","author":"Hajjeh","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12212_bib39","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1128\/JCM.00029-06","article-title":"Candidemia in Norway (1991 to 2003): results from a nationwide study","volume":"44","author":"Sandven","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12212_bib40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10096-004-1267-5","article-title":"Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2\u2010year multicentre study in Spain","volume":"24","author":"Peman","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/1469-0691.12212_bib41","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ijantimicag.2006.01.002","article-title":"Candidaemia in Europe: epidemiology and resistance","volume":"27","author":"Tortorano","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/1469-0691.12212_bib42","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/1469-0691.12212_bib43","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1128\/JCM.43.9.4434-4440.2005","article-title":"Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility","volume":"43","author":"Arendrup","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12212_bib44","doi-asserted-by":"crossref","first-page":"E246","DOI":"10.1111\/j.1469-0691.2012.03880.x","article-title":"EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST\u2010AFST)","volume":"18","author":"Arendrup","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12212_bib45","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2008"},{"key":"10.1111\/1469-0691.12212_bib46","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1111\/j.1469-0691.2011.03647.x","article-title":"EUCAST technical note on anidulafungin","volume":"17","author":"Arendrup","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12212_bib47","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.drup.2011.01.004","article-title":"Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species\u2010specific interpretive criteria","volume":"14","author":"Pfaller","year":"2011","journal-title":"Drug Resist Updat"},{"key":"10.1111\/1469-0691.12212_bib48","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1469-0691.2007.01899.x","article-title":"EUCAST Technical Note on fluconazole","volume":"14","author":"European Committee on Antimicrobial Susceptibility Testing\u2010Subcommittee on Antifungal Susceptibility Testing (EUCAST\u2010AFST)","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12212_bib49","doi-asserted-by":"crossref","first-page":"E16","DOI":"10.1111\/j.1469-0691.2011.03646.x","article-title":"EUCAST Technical Note on posaconazole*","volume":"17","author":"Arendrup","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12212_bib50","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1469-0691.2008.02087.x","article-title":"EUCAST Technical Note on voriconazole","volume":"14","author":"Subcommittee on Antifungal Susceptibility Testing (AFST)","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12212_bib51","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1128\/JCM.02072-06","article-title":"Five\u2010hour diagnosis of dermatophyte nail infections with specific detection of Trichophyton rubrum","volume":"45","author":"Brillowska\u2010Dabrowska","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12212_bib52","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1128\/AAC.01256-09","article-title":"Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27\u2013A3, Etest, disk diffusion, and agar dilution methods with RPMI and isosensitest media","volume":"54","author":"Arendrup","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12212_bib53","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3201\/eid0908.030069","article-title":"Candidemia in Finland, 1995\u20131999","volume":"9","author":"Poikonen","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/1469-0691.12212_bib54","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1128\/AAC.00355-12","article-title":"Caspofungin Etest susceptibility testing of Candida species: risk of misclassification of susceptible isolates of C. glabrata and C. krusei when adopting the revised CLSI caspofungin breakpoints","volume":"56","author":"Arendrup","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12212_bib55","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1128\/AAC.01193-12","article-title":"Stepwise development of homozygous S80P substitution in Fks1p conferring echinocandin resistance in Candida tropicalis","volume":"57","author":"Jensen","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12212_bib56","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1128\/JCM.42.1.115-118.2004","article-title":"Direct comparison of the BACTEC 9240 and BacT\/ALERT 3D automated blood culture systems for Candida growth detection","volume":"42","author":"Horvath","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12212_bib57","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/cid\/cis021","article-title":"Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient\u2010level quantitative review of randomized trials","volume":"54","author":"Andes","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"18","key":"10.1111\/1469-0691.12212_bib58","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/1469-0691.12038","volume":"2012","author":"Cuenca\u2010Estrella","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12212_bib59","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID* Guideline for the Diagnosis and Management of Candida Diseases 2012: non\u2010neutropenic adult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12212_bib60","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/1469-0691.12041","article-title":"ESCMID* Guideline for the Diagnosis and Management of Candida Diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)","volume":"18","author":"Ullmann","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"18","key":"10.1111\/1469-0691.12212_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12037","volume":"2012","author":"Ullmann","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12212_bib62","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/1469-0691.12042","article-title":"ESCMID* Guideline for the Diagnosis and Management of Candida Diseases 2012: patients with HIV infection or AIDS","volume":"18","author":"Lortholary","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12212_bib63","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/1469-0691.12040","article-title":"ESCMID* guideline for the diagnosis and management of Candida Diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp","volume":"18","author":"Hope","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12212_bib64","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/00365540903348336","article-title":"Typing of Candida isolates from patients with invasive infection and concomitant colonization","volume":"42","author":"Brillowska\u2010Dabrowska","year":"2010","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/1469-0691.12212_bib65","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1128\/AAC.01292-08","article-title":"Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing","volume":"53","author":"Arendrup","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12212_bib66","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/jac\/dkm095","article-title":"Acquired resistance to echinocandins in Candida albicans: case report and review","volume":"59","author":"Baixench","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12212_bib67","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1128\/AAC.00027-12","article-title":"The presence of an FKS mutation rather than MIC is an independent risk factor for failure of echinocandin therapy among patients with invasive Candidiasis due to Candida glabrata","volume":"56","author":"Shields","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12212_bib68","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/jac\/dkq136","article-title":"Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?","volume":"65","author":"Oxman","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12212_bib69","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1128\/AAC.01757-10","article-title":"Frequency of voriconazole resistance in vitro among Spanish clinical isolates of Candida spp. according to breakpoints established by the Antifungal Subcommittee of the European Committee on Antimicrobial Susceptibility Testing","volume":"55","author":"Cuenca\u2010Estrella","year":"2011","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14614348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14614348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:13:23Z","timestamp":1761117203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14614348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":69,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S1198743X14614348"],"URL":"https:\/\/doi.org\/10.1111\/1469-0691.12212","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/1469-0691.12212","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 European Society of Clinical Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}